Research Article

Association of Frailty with Serum Vitamin D and Parathyroid Hormone Levels

Volume: 13 Number: 1 January 1, 2022
EN

Association of Frailty with Serum Vitamin D and Parathyroid Hormone Levels

Abstract

Objective: Given that there is limited number of studies investigated joint effect of vitamin D and parathyroid hormone (PTH) in frailty syndrome, we aimed to evaluate association of frailty with serum vitamin D and PTH levels. Materials and Methods: This is a cross-sectional study conducted on individuals aged >65 years. In this cross-sectional study, data were collected using sociodemographic data sheet, Fatigue, Resistance, Ambulation, Illnesses, & Loss of Weight (FRAIL) scale and Study of Osteoporotic Fracture (SOF) index via face-to-face interview. The study included data from 513 subjects. Chi-square test was used in analyses. A p value<0.05 was considered as statistically significant. Results: The mean age was 71.9±6.4 years in the study population. Of the subjects, 75.2% were women and 77.2% were married while 61.8% were illiterate and 99.2% had own income. The prevalence of frailty elder was found as 46.8% by FRAIL scale and 51.3% by SOF index while pre-fail elder prevalence was found as 45.2% by FRAIL scale and 33.3% by SOF index. Conclusion: It was found that frail elder prevalence was increased by advancing age, female gender and presence of comorbidity and that low serum vitamin D and elevated PTH levels were closely associated with prevalence of frail elder.

Keywords

Supporting Institution

Destekleyen kurum bulunmamaktadır.

References

  1. 1. Rockwood K, Song X, MacKnight C et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173: 489–95. doi: 10.1503/cmaj.050051.
  2. 2. Topinkova E. Aging, disability and frailty. Ann Nutr Metab 2008; 52(Suppl 1): 6–11. https://doi.org/10.1159/000115340
  3. 3. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults. toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/ National Institute on Ageing Research Conference on Frailty in Older Adults. J Am Geriat Soc 2006; 54(6):991-1001. doi: 10.1111/j.1532-5415.2006.00745.x.
  4. 4. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004;59(3):255-63. doi: 10.1093/gerona/59.3.m255.
  5. 5. Rose M, Pan H, Levinson MR, Staples M. Can frailty predict complicated care needs and length of stay? Intern Med J 2014; 44(8),800-5. doi: 10.1111/imj.12502.
  6. 6. Byard RW. Frailty syndrome–medicolegal considerations. Journal of forensic and legal medicine. 2015;30:34-8. Doı: 10.1016/j.jflm.2014.12.016
  7. 7. Zaslavsky O, Cochrane BB, Thompson HJ, Woods NF, Herting JR, LaCroix AA. Frailty: A Review Of The First Decade Of Research. Biological Research For Nursing 2012; 15(4):422-432. doi: 10.1177/1099800412462866.
  8. 8. Shardell M, Hicks GE, Miller RR et al. Association of low vitamin D levels with the frailty syndrome in men and women. J Gerontol A Biol Sci Med Sci 2009; 64: 69–75. doi: 10.1093/gerona/gln007.

Details

Primary Language

English

Subjects

Geriatrics and Gerontology , Health Care Administration

Journal Section

Research Article

Publication Date

January 1, 2022

Submission Date

June 6, 2021

Acceptance Date

September 10, 2021

Published in Issue

Year 2022 Volume: 13 Number: 1

EndNote
Göçer Ş, Balbaloğlu Ö (January 1, 2022) Association of Frailty with Serum Vitamin D and Parathyroid Hormone Levels. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 13 1 119–125.